Aqueous extract of Sargentodoxa cuneata alleviates ulcerative colitis and its associated liver injuries in mice through the modulation of intestinal flora and related metabolites

Abstract

BackgroundUlcerative colitis (UC) is a refractory disease worldwide. Liver injury can be found clinically with UC, and now, it is found that gut dysbiosis is an important mechanism in the pathogenesis of UC. Sargentodoxa cuneata has been used as a traditional Chinese medicine and is commonly used clinically for the treatment of UC. The main objective of this study was to investigate the intrinsic mechanisms of Sargentodoxa cuneata in the treatment of UC and its associated liver injuries from the perspective of intestinal flora and related metabolites.MethodsUltra-performance liquid chromatography-mass spectrometry was used to identify the components in the aqueous extract of Sargentodoxa cuneata (AESc). Mice with UC induced by dextran sulfate sodium were used to study the effects of AESc on UC and its associated liver injuries. Furthermore, 16S rRNA gene sequencing and analysis were performed on intestinal contents, and correlation analysis of intestinal flora with short-chain fatty acids (SCFAs) and organic acids was performed.ResultsA total of 114 compounds were identified in AESc. AESc improved disease activity index scores, liver index, and colon length in mice with UC and had a good protective effect on intestine and liver injuries. Moreover, the administration of AESc regulated gut microbiota dysbiosis and the levels of a few SCFAs and organic acids in mice with UC. In addition, the correlation analysis results showed that the Megamonas and Bifidobacterium were the key intestinal flora related to the levels of differential SCFAs and organic acids in mice with UC after AESc intervention.ConclusionAESc has a good protective effect on UC and UC related liver injuries. Modulation of the intestinal flora and its metabolites (SCFAs and a few organic acids) is an important pathway for AESc in the treatment of UC and also provides a rationale for the clinical use of Sargentodoxa cuneata in the treatment of UC.

Protective Effect of Mesenchymal Stem Cell Active Factor Combined with Alhagi maurorum Extract on Ulcerative Colitis and the Underlying Mechanism

“…Figure 2 shows the total ion chromatograms of the samples in both positive and negative modes. The saccharides, carbohydrates and their derivatives, as identified by the experiment, were alpha-piperidinobutiophenone, beta-d-glucose, gamma-aminobutyric acid, and caryophyllene oxide: (4ar,5s)-9,9a-dihydroxy-3,4a,5-trimethyl-5,6,7,8,8a,9-hexahydro-4 h-benzo [1] benzofuran-2-one; 1,2-disinapoyl diglucoside; 1,2-disinapoyl diglucoside; and 1,2,3-benzenetriol (Figure 2 and Supplementary File S1 (Table S1)).…”

“…Although the exact etiology remains unclear, it is widely believed that genetic predisposition, environmental triggers, and abnormal immune response factors contribute to its development. UC typically leads to epithelial cell ulceration and necrosis in the colon [1,2]. Excessive and inappropriate inflammatory reactions along with the presence of certain cytokines (such as IL-1β, IL-8, IL-6) and autoimmune diseases play a central role in colonic inflammation.…”